Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lip and Oral Cavity Carcinoma
|
172 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.720 | 1.000 | 2 | 2017 | 2018 | |||||
Oral lesion
|
5 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.700 | 0 | ||||||||
Malignant neoplasm of prostate
|
1082 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.030 | 0.333 | 3 | 2017 | 2018 | |||||
Prostate carcinoma
|
1168 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.030 | 0.333 | 3 | 2017 | 2018 | |||||
Age related macular degeneration
|
663 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.020 | 0.500 | 2 | 2017 | 2019 | |||||
cervical cancer
|
268 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.020 | 1.000 | 2 | 2016 | 2016 | |||||
Cervix carcinoma
|
283 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.020 | 1.000 | 2 | 2016 | 2016 | |||||
Hypertensive disease
|
1085 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.020 | 1.000 | 2 | 2018 | 2019 | |||||
Intracranial Aneurysm
|
150 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.020 | 1.000 | 2 | 2011 | 2018 | |||||
Malignant neoplasm of mouth
|
184 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Malignant tumor of cervix
|
245 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.020 | 1.000 | 2 | 2016 | 2016 | |||||
Rheumatoid Arthritis
|
2387 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.020 | 2 | 2008 | 2013 | ||||||
Agenesis
|
44 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Ankylosing spondylitis
|
609 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Bladder Neoplasm
|
281 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Carcinoma of bladder
|
309 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Caries (morphologic abnormality)
|
33 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Cataract
|
124 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Childhood Leukemia
|
140 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Childhood Osteosarcoma
|
151 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Coronary Artery Disease
|
1577 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1 | 2014 | 2014 | ||||||
Dental caries
|
126 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Dental Fluorosis, Acquired
|
10 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Dural Arteriovenous Fistula
|
2 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Glaucoma, Open-Angle
|
236 | 0.600 | 0.640 | 16 | 55477894 | intron variant | C/T | snv | 0.19 | 0.010 | 1.000 | 1 | 2010 | 2010 |